| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Non-evidence-based ICD implantations in the United States.
|
JAMA
|
2011
|
5.05
|
|
2
|
Effect of clinical decision-support systems: a systematic review.
|
Ann Intern Med
|
2012
|
3.42
|
|
3
|
Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis.
|
Arch Intern Med
|
2008
|
2.96
|
|
4
|
An economic evaluation of prolonged mechanical ventilation.
|
Crit Care Med
|
2007
|
2.93
|
|
5
|
Evaluating human papillomavirus vaccination programs.
|
Emerg Infect Dis
|
2004
|
2.47
|
|
6
|
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
|
Heart Rhythm
|
2013
|
2.22
|
|
7
|
Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
2.18
|
|
8
|
Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.
|
Obstet Gynecol
|
2013
|
2.17
|
|
9
|
Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax.
|
Ann Intern Med
|
2005
|
1.69
|
|
10
|
Enabling health care decisionmaking through clinical decision support and knowledge management.
|
Evid Rep Technol Assess (Full Rep)
|
2012
|
1.68
|
|
11
|
Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review.
|
Ann Intern Med
|
2014
|
1.67
|
|
12
|
Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing.
|
J Gen Intern Med
|
2008
|
1.67
|
|
13
|
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.
|
J Gen Intern Med
|
2011
|
1.62
|
|
14
|
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
|
Ann Intern Med
|
2003
|
1.61
|
|
15
|
Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator.
|
Health Aff (Millwood)
|
2005
|
1.60
|
|
16
|
Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis.
|
Eur J Endocrinol
|
2008
|
1.59
|
|
17
|
Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.
|
Obstet Gynecol
|
2013
|
1.56
|
|
18
|
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
|
Cancer
|
2010
|
1.53
|
|
19
|
Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis.
|
Cardiol J
|
2011
|
1.50
|
|
20
|
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
|
AIDS
|
2006
|
1.48
|
|
21
|
Systematic review of the incidence of sudden cardiac death in the United States.
|
J Am Coll Cardiol
|
2011
|
1.47
|
|
22
|
Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis.
|
Am J Med
|
2004
|
1.44
|
|
23
|
ECG-based signal analysis technologies for evaluating patients with acute coronary syndrome: a systematic review.
|
J Electrocardiol
|
2012
|
1.39
|
|
24
|
Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
|
J Cardiovasc Electrophysiol
|
2009
|
1.19
|
|
25
|
Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.
|
Am J Respir Crit Care Med
|
2009
|
1.16
|
|
26
|
Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV.
|
Am J Public Health
|
2007
|
1.10
|
|
27
|
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
|
Gynecol Oncol
|
2008
|
1.09
|
|
28
|
Evaluating cough assessment tools: a systematic review.
|
Chest
|
2013
|
1.07
|
|
29
|
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis.
|
J Crit Care
|
2003
|
1.06
|
|
30
|
HIV testing of at risk patients in a large integrated health care system.
|
J Gen Intern Med
|
2007
|
1.03
|
|
31
|
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
|
Am Heart J
|
2005
|
1.01
|
|
32
|
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.
|
Am Heart J
|
2008
|
1.01
|
|
33
|
Evidence-based practice for mere mortals: the role of informatics and health services research.
|
J Gen Intern Med
|
2002
|
0.98
|
|
34
|
Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race?
|
Ann Noninvasive Electrocardiol
|
2011
|
0.96
|
|
35
|
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.
|
J Clin Oncol
|
2013
|
0.94
|
|
36
|
Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
|
Gastrointest Endosc
|
2004
|
0.92
|
|
37
|
Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.
|
Pediatrics
|
2002
|
0.91
|
|
38
|
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
|
Am Heart J
|
2002
|
0.91
|
|
39
|
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.
|
Am Heart J
|
2007
|
0.90
|
|
40
|
Cost-effectiveness as an outcome in randomized clinical trials.
|
Clin Trials
|
2006
|
0.89
|
|
41
|
Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.
|
J Card Fail
|
2011
|
0.89
|
|
42
|
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis.
|
BMC Pediatr
|
2012
|
0.88
|
|
43
|
Identifying research needs for improving health care.
|
Ann Intern Med
|
2012
|
0.88
|
|
44
|
Prioritization of patient-centered comparative effectiveness research for osteoarthritis.
|
Ann Intern Med
|
2014
|
0.88
|
|
45
|
Genomic tests for ovarian cancer detection and management.
|
Evid Rep Technol Assess (Full Rep)
|
2006
|
0.88
|
|
46
|
Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation.
|
Am Heart J
|
2013
|
0.87
|
|
47
|
Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
|
J Cardiovasc Electrophysiol
|
2010
|
0.86
|
|
48
|
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.
|
PLoS One
|
2011
|
0.85
|
|
49
|
Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.
|
Am Heart J
|
2012
|
0.84
|
|
50
|
Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.
|
Chest
|
2013
|
0.83
|
|
51
|
Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism.
|
Arch Intern Med
|
2007
|
0.82
|
|
52
|
Prioritization of research addressing management strategies for ductal carcinoma in situ.
|
Ann Intern Med
|
2014
|
0.80
|
|
53
|
A pilot study using an implantable device to characterize cardiac arrhythmias in hemodialysis patients: implications for future research.
|
Ann Noninvasive Electrocardiol
|
2012
|
0.80
|
|
54
|
Oral contraceptive use for the primary prevention of ovarian cancer.
|
Evid Rep Technol Assess (Full Rep)
|
2013
|
0.80
|
|
55
|
Cost-effectiveness of the implantable cardioverter defibrillator.
|
Card Electrophysiol Rev
|
2003
|
0.80
|
|
56
|
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.
|
Am Heart J
|
2012
|
0.79
|
|
57
|
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies.
|
Am Heart J
|
2010
|
0.77
|
|
58
|
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice.
|
Am Heart J
|
2011
|
0.77
|
|
59
|
Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance.
|
Patient Prefer Adherence
|
2013
|
0.77
|
|
60
|
Decision science and cervical cancer.
|
Cancer
|
2003
|
0.76
|
|
61
|
Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic review.
|
Arthritis Care Res (Hoboken)
|
2012
|
0.76
|
|
62
|
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
|
PLoS One
|
2012
|
0.76
|
|
63
|
Noninvasive imaging for coronary artery disease: a technology assessment for the Medicare Coverage Advisory Commission.
|
Am Heart J
|
2007
|
0.75
|
|
64
|
Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant.
|
Ann Am Thorac Soc
|
2013
|
0.75
|
|
65
|
When to implant an ICD following a myocardial infarction?
|
Heart Rhythm
|
2013
|
0.75
|
|
66
|
Prioritization of research addressing antipsychotics for adolescents and young adults with bipolar disorder.
|
Ann Intern Med
|
2014
|
0.75
|
|
67
|
Priorities for comparative effectiveness reviews in cardiovascular disease.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.75
|
|
68
|
Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment.
|
Am Heart J
|
2013
|
0.75
|
|
69
|
Policy rounds: a new series and a call for papers.
|
Med Decis Making
|
2008
|
0.75
|
|
70
|
Modeling bioterrorism and disaster preparedness: SMDM's recommendations for design and reporting.
|
Med Decis Making
|
2009
|
0.75
|